´ëÇѸðüžÆÀÇÇÐȸ Á¦30Â÷ Çмú´ëȸ : 2024-06-15
±³À°ÀÏÀÚ : 2024-06-15
±³À°Àå¼Ò : Á¦ÁÖ ¸ÞÁ¾±Û·¡µåÈ£ÅÚ ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ : ´ëÇѸðüžÆÀÇÇÐȸ Á¦30Â÷ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѸðüžÆÀÇÇÐȸ
´ã´çÀÚ : ¹Ú¼±È
¿¬¶ôó : 02-2650-5274
À̸ÞÀÏ : office@ksmfm.or.kr
±³À°Á¾·ù : »êºÎÀΰú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : Á¦ÁÖƯº°ÀÚÄ¡µµ
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 110,000¿ø
ºñ°í Àü¹®ÀÇ(ȸ¿ø10¸¸¿ø/ºñȸ¿ø11¸¸¿ø)Àü°øÀÇ(6¸¸¿ø)°£È£»ç/±âŸ(3¸¸¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 08:00~08:25 µî·Ï ( )
±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 08:25~08:30 °³È¸»ç ( )
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 08:30~08:45 ºÐ¸¸ ½Ã°£°ú ÁøÅë °µµ¸¦ ÁÙÀ̱â À§ÇÑ »ê¸ð ÀڱüöÃà ¹ÙÅÁÀÇ VR ½Ã½ºÅÛ È¿´É Æò°¡ Á¶±ÝÁØ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 08:45~09:00 ¹Ì¼¼¸ÕÁö ±âÀÎ Á¶»ê ¿¹Ãø Èļº À¯ÀüÀÚ ¹ß±¼À» À§ÇÑ Á¦´ëÇ÷ ¸ÞÆ¿È ºÐ¼® ¿¬±¸ ¹Ú¼±È(ÀÌÈÀÇ´ë)
±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:00~09:15 Æ丵Çмú»ó ½Ã»ó ¹× ³í¹®¹ßÇ¥ ( )
±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:15~09:30 ¸ðüÅÂ¾Æ ÀþÀº ÀÇÇÐÀÚ»ó ½Ã»ó ¹× ³í¹®¹ßÇ¥ ( )
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:30~09:40 (±¸¿¬) ÀӽŠÁß °íÇ÷¾Ð ÁúȯÀÇ À¯ÀüÀû ¼ÒÀΰú »ýÈ°½À°üÀÌ Àå±âÀû ½ÉÇ÷°ü À§Çèµµ¿¡ ¹ÌÄ¡´Â ¿µÇâ ±èÁöȸ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:40~09:50 (±¸¿¬) Exploring the applicability of Methacrylate Carboxymethyl Chitosan for the fetal treatment of gastroschisis À§Á¤ÇÏ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 09:50~10:00 (±¸¿¬) Clinical significance of ¡®Dual Positivity¡¯ for neural tube defect and Down syndrome on maternal serum screening ÇÔ¼öÁö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:00~10:10 (±¸¿¬) Shotgun metagenomics of vaginal microbiome in cervical shortening: Implications for preterm birth risk ¼Õ°¡Çö(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:10~10:20 (±¸¿¬) Adverse Obstetric Outcomes Associated with Protocol of Embryo Transfer È«À¯¹Ì(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:20~10:30 (±¸¿¬) Isolation of circulating fetal cells using immuno-affinity & microfluidic method for non-invasive prenatal diagnostic test Á¤¿µ¹Ì(°í·ÁÀÇ´ë)
ÈÞ½Ä 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:30~10:50 Coffee Break ( )
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 10:50~11:15 First and Second Stage Labor Management (Guideline Update) ±è½Âö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 11:15~11:40 Diagnosis and Management of Suspected Fetal Growth Restriction: an Evidence-based Approach (SMFM vs. ISUOG) À̽¹Ì(¼¿ïÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 11:40~11:50 Discussion ( )
±âŸ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 11:50~12:00 °ø·ÎÆнûó ( )
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 12:00~12:20 Current Update on Vaginal Micronized Progesterone to Prevent Miscarriage ¼³ÇöÁÖ(°æÈñÀÇ´ë)
ÈÞ½Ä 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 12:20~13:10 Lunch ( )
Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:10~13:15 (Æ÷½ºÅÍ) ÀΰøÁö´É ±â¹Ý ºñħ½ÀÀû ÅÂ¾Æ ½É¹Úµ¿ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ °³¹ß À±¼öºó(¼¿ïÀÇ´ë ¸¶ÃëÅëÁõÀÇÇаú)
Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:15~13:20 (Æ÷½ºÅÍ) Prevention of obstetric anal sphincter injuries with episiotomy : A retrospective cohort study À±ÁÖÈñ(¿¬¼¼ÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:20~13:25 (Æ÷½ºÅÍ) Development of a Nomogram for Birth Weight Prediction Using Prenatal Serum Screening Test and sFLT-1 Level ÀÌÀ¯¸®(¼º±Õ°üÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:25~13:30 (Æ÷½ºÅÍ) Comparison of Placenta Ultrastructure in high and low Exposure to Particulate Matter 2.5 during pregnancy ÀÌ°¡ÀÎ(ÀÌÈÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:30~13:35 (Æ÷½ºÅÍ) The effects of DLK-1 and the IGF system on fetal growth restriction ÀÓµµÈ(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:35~13:40 (Æ÷½ºÅÍ) Systematic Proteome Profiling of Maternal Plasma for Development of Predictive Biomarker of Preeclampsia ¾ç¼öÁö(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:40~13:50 (±¸¿¬) Comparative Analysis of Early Prediction Machine Learning Models for A1GDM and A2GDM: Differentiating Risk Factors ±è³ª¸®(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 13:50~14:00 (±¸¿¬) The Effect of Microplastics on the Human Pregnancy at the Maternal Fetal Interface ÇãÇý¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:00~14:10 (±¸¿¬) A multi-center, retrospective study comparing maternal and neonatal outcomes based on changes in HbA1c levels during the first and second trimester of pregnancy with overt diabetes. ±è¹ÌÁÖ(°æºÏÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:10~14:20 (±¸¿¬) Administration of Weissella confusa WIKIM51 modulates hepatic lipogenesis altered by maternal diet during pregnancy in a sex-dependent manner. ±è¼ö¹Î(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:20~14:30 (±¸¿¬) The adverse effect of nausea and vomiting during the first trimester might be different according to maternal body mass index ±è¼®¿µ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:30~14:40 (±¸¿¬) Effectiveness of CD45 and CD56 cell surface negative markers for removal of maternal mononuclear cells in the enrichment of trophoblast from cervix sampling of pregnant women ÀåÀ±(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 14:40~15:00 (±¸¿¬) Postpartum Preeclampsia-Eclampsia: Defining and Management ±èÈ£¿¬(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ Á¦ÁÖ¸ÞÁ¾±Û·¡µå ÄÁº¥¼ÇȦ 15:00~15:20 What¡¯s Known & What¡¯s New? (Focusing on Continuous Glucose Monitoring & Non-insulin Antidiabetic Treatment) È«¼öºó(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 06¿ù 15ÀÏ 15:20~15:40 Placenta Accreta Spectrum without Previa : Difficulties in Diagnosis ±ÇÇϾá(¿¬¼¼ÀÇ´ë)
±âŸ 06¿ù 15ÀÏ 15:40~15:50 Çмú»ó ½Ã»ó ( )
±âŸ 06¿ù 15ÀÏ 15:50~16:00 ÃÑȸ ( )
±âŸ 06¿ù 15ÀÏ 16:00~16:05 Æóȸ»ç ( )